The KDIGO guidelines for diabetes management in CKD describes first-line treatment that comprises RAAS inhibition and SGLT-2 inhibitors, with the addition of a nonsteroidal MRA for patients with residual albuminuria (in line with current PBS prescribing criteria) and GLP-1 receptor agonists for additional glycaemic and cardiovascular benefits
With your permission I may include excerpts here (always modifiable by you.) 23 December 2021 - Reader W wrote: Dear Dr
Known as the "Master Antioxidant," glutathione plays a vital role in protecting cells from oxidative stress, promoting a clear, radiant complexion, and enhancing overall well-being
Smaller meals empty faster and cause less discomfort
Once removed from the refrigerator for injection, most formulations remain stable at room temperature for a limited window, typically 28 days depending on your compounding pharmacy's specific formulation
doi: 10.1172/JCI25083 84 LuongoCDenticeMSalvatoreD